Ligands and activators of nuclear hormone receptors regulate epidermal differentiation during fetal rat skin development

被引:79
作者
Kömüves, LG
Hanley, K
Jiang, Y
Elias, PM
Williams, ML
Feingold, KR
机构
[1] Dept Vet Affairs Med Ctr, Dermatol Serv, San Francisco, CA 94121 USA
[2] Dept Vet Affairs Med Ctr, Med Serv, San Francisco, CA 94121 USA
[3] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA
关键词
dihydrotestosterone; estrogen; filaggrin; FXR; glucocorticoids; loricrin; PPAR alpha; thyroid hormone;
D O I
10.1046/j.1523-1747.1998.00296.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Because a protective barrier is essential for life, the development of the epidermis and stratum corneum must be completed prior to birth, The epidermal permeability barrier is comprised of corneocytes embedded in a lipid enriched matrix, Recent studies from our laboratory, using an explant model of fetal rat skin development that closely parallels in utero development, have shown that hormones and other activators of members of the nuclear receptor family regulate permeability barrier ontogenesis by stimulating lipid metabolism and the formation of the extracellular Lipid lamellae, Using this model we sought to determine whether these hormones and nuclear activators also regulate keratinocyte differentiation during fetal development, Profilaggrin/filaggrin and loricrin expression, assessed by in situ hybridization and by immunohistochemistry, were progressively increased during epidermal ontogenesis, Whereas profilaggrin/filaggrin and loricrin were not expressed at day 17 of gestation, by day 19 both were present in the upper layers of the epidermis and both became still more abundant by day 21, These developmental changes also occurred in fetal skin explants cultured in vitro for 4 d, although the expression levels did not appear as robust as in utero, Whereas neither profilaggrin/filaggrin nor loricrin were expressed in control explants cultured for 2 d, they were seen in explants treated with either thyroid hormone, glucocorticoids, or estrogens, Tn contrast, dihydrotestosterone treatment delayed the expression of profilaggrin/filaggrin and loricrin, Moreover, both clofibrate, a peroxisome proliferator-gctivated receptor-a ligand, and juvenile hormone III, a farnesoid X-activated receptor activator, markedly accelerated fetal epidermal differentiation, stimulating both profilaggrin/filaggrin and loricrin expression. Our results demonstrate that several hormones and activators of nuclear hormone receptors regulate epidermal differentiation during fetal development, affecting key constituents of both keratohyalin granules and the cornified envelope, Thus, a variety of ligands/activators of nuclear receptors accelerate not only permeability barrier ontogenesis, but also the expression of structural proteins essential for stratum corneum formation.
引用
收藏
页码:429 / 433
页数:5
相关论文
共 30 条
[11]   EPIDERMAL DIFFERENTIATION - THE BARE ESSENTIALS [J].
FUCHS, E .
JOURNAL OF CELL BIOLOGY, 1990, 111 (06) :2807-2814
[12]   Acceleration of barrier ontogenesis in vitro through air exposure [J].
Hanley, K ;
Jiang, Y ;
Elias, PM ;
Feingold, KR ;
Williams, ML .
PEDIATRIC RESEARCH, 1997, 41 (02) :293-299
[13]   Hormonal basis for the gender difference in epidermal barrier formation in the fetal rat - Acceleration by estrogen and delay by testosterone [J].
Hanley, K ;
Rassner, U ;
Jiang, Y ;
Vansomphone, D ;
Crumrine, D ;
Komuves, L ;
Elias, PM ;
Feingold, KR ;
Williams, ML .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11) :2576-2584
[14]   Activators of the nuclear hormone receptors PPAR alpha and FXR accelerate the development of the fetal epidermal permeability barrier [J].
Hanley, K ;
Jiang, Y ;
Crumrine, D ;
Bass, NM ;
Appel, R ;
Elias, PM ;
Williams, ML ;
Feingold, KR .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (03) :705-712
[15]   Epidermal barrier ontogenesis: Maturation in serum-free media and acceleration by glucocorticoids and thyroid hormone but not selected growth factors [J].
Hanley, K ;
Rassner, U ;
Elias, PM ;
Williams, ML ;
Feingold, KR .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (03) :404-411
[16]  
HANLEY K, 1997, PEDIATR RES, V42, P1
[17]  
HAYDOCK PV, 1986, J BIOL CHEM, V261, P2520
[18]  
HOATH SB, 1990, J DEV PHYSIOL, V13, P41
[19]  
Hohl Daniel, 1993, P151
[20]   TARGETING EXPRESSION OF A DOMINANT-NEGATIVE RETINOIC ACID RECEPTOR MUTANT IN THE EPIDERMIS OF TRANSGENIC MICE RESULTS IN LOSS OF BARRIER FUNCTION [J].
IMAKADO, S ;
BICKENBACH, JR ;
BUNDMAN, DS ;
ROTHNAGEL, JA ;
ATTAR, PS ;
WANG, XJ ;
WALCZAK, VR ;
WISNIEWSKI, S ;
POTE, J ;
GORDON, JS ;
HEYMAN, RA ;
EVANS, RM ;
ROOP, DR .
GENES & DEVELOPMENT, 1995, 9 (03) :317-329